Tuesday, December 6, 2022
Home Tags Molnupiravir

Tag: Molnupiravir

WHO updates its treatment guidelines to include Molnupiravir

The World Health Organization (WHO) has updated its living guidelines on C-19 therapeutics to include a conditional recommendation on molnupiravir, a new...

Molnupiravir effective against Omicron, could reduce deaths: Study

NEW DELHI:  A new study revealed that a five-day course of antiviral drug, Molnupiravir, could be effective against highly contagious Omicron and...

Confusion over Molnupiravir ? Let’s understand

The ICMR’s National Task Force for COVID-19 has decided against including anti-viral drug Molnupiravir in the Clinical Management Protocol for COVID-19 as...

India to become hub for Covid-19 antiviral medicines

India will become the largest global hub for COVID-19 antiviral general drug production after the drug controller granted emergency-use authorization to several...

Molnupiravir has serious safety concerns: ICMR

New Delhi: The antiviral drug molnupiravir, which recently got approval from the drug regulator and is being launched by several local drug makers,...

Dr Reddy’s to launch anti-Covid drug Molnupiravir at Rs 35 per...

Dr Reddy’s Laboratories has announced that it will launch the most affordably-priced molnupiravir capsules 200 mg under its brand name Molflu across...

CDSCO approves Corbevax, Covovax and Molnupiravir for restricted use

The government yesterday announced that it has approved emergency use of two more C-19 vaccines and anti-viral drug Molnupiravir.

DCGI gives nod to Sun Pharma arm for Molnupiravir in India

Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from the Drugs Controller...

Sun Pharma to introduce Molnupiravir in India

Sun Pharma recently said that it is gearing up to introduce Merck Sharpe Dohme (MSD) and Ridgeback’s Molnupiravir under the brand name...

Pharma companies are awaiting DCGI nod to launch Covid-19 drug in...

MUMBAI: Sun Pharma said on Thursday it is gearing up to introduce antiviral Covid-19 drug, molnupiravir under the brand Molxvir at "an economical price'' in India....

Explained: What is oral antiviral drug Molnupiravir ?

Molnupiravir is a trending word and news headlines now a days. But what is antiviral drug Molnupiravir ? Let's know all about...

UK becomes first country to approve anti-Covid pill

London: Britain on Thursday approved the use of Merck's antiviral pill to treat patients suffering from mild to moderate Covid-19, the Medicines and Healthcare products...

Anti-Covid drug manufacturers move to CDSCO for permission

NEW DELHI:  Hopes have risen for the approval of the first Covid-19 antiviral drug in India with two drug makers reaching the...

These Indian Pharma Cos seek nod from DCGI for marketing Anti...

Hyderabad-based Natco Pharma Limited and Hetero have sought marketing authorisation for their anti-Covid drug molnupiravir from the drug regulator, people in the know told ET. The Subject...

Optimus Pharma seeks nod to produce generic Covid Pill: Hyderabad

Indian bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co’s oral COVID-19...

EU Regulator starts real-time review of anti viral drug Molnupiravir

Merck said today that the European Union’s (EU) drug regulator has initiated a real-time review of its experimental C-19 antiviral drug for...

USFDA advisers to review Merck’s Molnupiravir soon

A panel of outside advisers to the US health regulator will meet late next month to discuss whether to authorise Merck &...

Merck and Ridgeback seek EUA from USFDA for Molnupiravir

Merck and Ridgeback Biotherapeutics yesterday announced that Merck has submitted an Emergency Use Authorisation (EUA) application to the US Food and Drug...

Merck asks USFDA to authorize promising Anti Covid Pill

Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the...

Aurobindo Pharma, MSN Labs seek DCGI nod for Phase-III trials of...

Two Indian pharmaceutical companies have sought permission from India’s drug regulator to continue phase III trials on antiviral drug molnupiravir in mild C-19 patient....

Hetero seeks EU Authorisation from DCGI for Molnupiravir

HYDERABAD: The Hyderabad-based Hetero Drugs announced interim results from Phase III clinical trials of Molnupiravir in treatment of mild C-19 patients on Friday,...

These 5 Pharma giants join hands to test oral C-19 drug

HYDERABAD: The drug Molnupiravir — an antiviral oral drug which is being touted as a candidate for treatment of mild cases of C-19...

Molnupiravir: 24 घंटे में खत्म हो जाएगा C-19 का Infection: US...

Molnupiravir: 24 घंटे में खत्म हो जाएगा C-19 का Infection: US Scientists न्यूयॉर्क, IANS: C-19 वायरस के खात्मे के लिए...

Latest posts

Govt Job: For M.Pharm as Junior Associate at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab, and the...

Authors

67 POSTS0 COMMENTS
40 POSTS0 COMMENTS
32 POSTS0 COMMENTS
15 POSTS0 COMMENTS
13 POSTS0 COMMENTS
11 POSTS0 COMMENTS
6 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS